Clinical Trial: A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase II Study of Pemetrexed in Recurrent Cervical Adenocarcinomas

Brief Summary: Patients with advanced or recurrent adenocarcinoma or adenosquamous cell carcinoma of the cervix will receive Pemetrexed.